Your session is about to expire
← Back to Search
Mobile Monitoring Device for Respiratory Disorders
N/A
Waitlist Available
Led By Sharon Chinthrajah, MD
Research Sponsored by Stanford University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
age 1 month or older with a diagnosis of chronic respiratory disease (ex. asthma, COPD), an acute respiratory illness or a healthy volunteer
Age 1 month or older with a diagnosis of chronic respiratory disease (ex. asthma, COPD), an acute respiratory illness or a healthy volunteer
Must not have
Significant cognitive impairment
Non-English speaking
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 2 years
Awards & highlights
No Placebo-Only Group
Summary
This trial is looking at ways to help patients with respiratory disease monitor their symptoms and compliance with medication at home, as well as their vital signs, lung sounds, and lung function.
Who is the study for?
This trial is for individuals aged 1 month or older with chronic respiratory diseases like asthma or COPD, acute respiratory illnesses, or even healthy volunteers. Participants must be able to give consent themselves or through a parent if underage and speak English. Those with significant cognitive impairment cannot join.
What is being tested?
The study is testing the use of mobile monitoring devices that allow patients to track their respiratory health at home. This data will then be used by medical providers to potentially improve patient care and overall quality of life.
What are the potential side effects?
Since this trial involves non-invasive remote monitoring devices, there are no direct side effects from medications as in drug trials. However, participants may experience inconvenience or discomfort associated with using these devices regularly.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am over 1 month old and have a chronic respiratory condition, an acute respiratory illness, or am healthy.
Select...
I am over 1 month old and have a chronic respiratory condition, an acute respiratory illness, or am healthy.
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I have significant memory or thinking problems.
Select...
I do not speak English.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 2 years
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 2 years
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Asthma Control Test (ACT)
PROMIS-10 survey
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: Mobile MonitoringExperimental Treatment1 Intervention
Participants will be asked to use a smartphone or tablet application for remote monitoring or respiratory health. They will be followed over time with surveys as well as chart review to assess effects of adding these mobile monitoring elements to their standard care.
Find a Location
Who is running the clinical trial?
Stanford UniversityLead Sponsor
2,468 Previous Clinical Trials
17,496,082 Total Patients Enrolled
Sharon Chinthrajah, MDPrincipal InvestigatorStanford University, Sean N. Parker Center for Allergy and Asthma Research
2 Previous Clinical Trials
484 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am over 1 month old and have a chronic respiratory condition, an acute respiratory illness, or am healthy.I have significant memory or thinking problems.I am over 1 month old and have a chronic respiratory condition, an acute respiratory illness, or am healthy.I do not speak English.
Research Study Groups:
This trial has the following groups:- Group 1: Mobile Monitoring
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Chronic Respiratory Disease Patient Testimony for trial: Trial Name: NCT04739943 — N/A
Share this study with friends
Copy Link
Messenger